| Literature DB >> 30478327 |
Ellie Sherrard-Smith1, Jamie T Griffin2, Peter Winskill3, Vincent Corbel4, Cédric Pennetier4,5, Armel Djénontin6, Sarah Moore7,8,9, Jason H Richardson10, Pie Müller7,8, Constant Edi11, Natacha Protopopoff12, Richard Oxborough13, Fiacre Agossa14, Raphael N'Guessan12, Mark Rowland12, Thomas S Churcher3.
Abstract
Indoor residual spraying (IRS) is an important part of malaria control. There is a growing list of insecticide classes; pyrethroids remain the principal insecticide used in bednets but recently, novel non-pyrethroid IRS products, with contrasting impacts, have been introduced. There is an urgent need to better assess product efficacy to help decision makers choose effective and relevant tools for mosquito control. Here we use experimental hut trial data to characterise the entomological efficacy of widely-used, novel IRS insecticides. We quantify their impact against pyrethroid-resistant mosquitoes and use a Plasmodium falciparum transmission model to predict the public health impact of different IRS insecticides. We report that long-lasting IRS formulations substantially reduce malaria, though their benefit over cheaper, shorter-lived formulations depends on local factors including bednet use, seasonality, endemicity and pyrethroid resistance status of local mosquito populations. We provide a framework to help decision makers evaluate IRS product effectiveness.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30478327 PMCID: PMC6255894 DOI: 10.1038/s41467-018-07357-w
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919